Enovis Corp

자세한 내용은 Enovis Corp 회사

Enovis Corporation is a medical technology company. It is focused on developing clinically differentiated solutions by manufacturing and distributing high-quality medical devices with a range of products used for reconstructive surgery, rehabilitation, pain management and physical therapy. It operates through two segments: Prevention & Recovery and Reconstructive. The Prevention & Recovery segment provides orthopedic and recovery science solutions, including devices, software, and services across the patient care continuum from injury prevention to rehabilitation after surgery, injury, or from degenerative diseases. The Prevention & Recovery products are marketed under several brand names, such as DJO. The Reconstructive segment provides surgical implant solutions, offering a comprehensive suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger and surgical productivity tools. It also operates a Enovis Growth eXcellence business system (EGX).

회사 정보

종목 코드 ENOV

회사 이름Enovis Corp

상장일May 08, 2008

설립일1998

CEOMr. Damien Mcdonald

직원 수7367

유형Ordinary Share

회계 연도 종료May 08

주소2711 Centerville Road

도시WILMINGTON

증권 거래소NYSE Consolidated

국가United States of America

우편 번호19808

전화13022529160

웹사이트https://www.enovis.com/

종목 코드 ENOV

상장일May 08, 2008

설립일1998

회사 임원

이름

이름/직위

직위

주식 보유

변동

Mr. Daniel Alexis Pryor

Executive Vice President - Strategy and Business Development

104.51K

+18.11%

Mr. Damien Mcdonald

Chief Executive Officer, Director

96.30K

--

Mr. Terry D. Ross

Group President - Prevention and Recovery

36.11K

+90.73%

Ms. Sharon L. Wienbar

Independent Chairman of the Board

28.26K

+30.46%

Mr. Rajiv Vinnakota

Independent Director

20.37K

+47.89%

Mr. Liam J. Kelly

Independent Director

15.27K

+76.12%

Ms. Barbara W. Bodem

Independent Director

10.52K

+168.36%

Dr. Christine Ortiz, Ph.D.

Independent Director

10.52K

+168.36%

Mr. Philip A. Okala

Independent Director

--

Ms. Angela S. Lalor

Independent Director

--

이름

이름/직위

직위

주식 보유

변동

Mr. Daniel Alexis Pryor

Executive Vice President - Strategy and Business Development

104.51K

+18.11%

Mr. Damien Mcdonald

Chief Executive Officer, Director

96.30K

--

Mr. Terry D. Ross

Group President - Prevention and Recovery

36.11K

+90.73%

Ms. Sharon L. Wienbar

Independent Chairman of the Board

28.26K

+30.46%

Mr. Rajiv Vinnakota

Independent Director

20.37K

+47.89%

Mr. Liam J. Kelly

Independent Director

15.27K

+76.12%

수익 분석

통화: USD마지막 업데이트: Sun, Jul 6

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

FY2018

사업별USD

이름

수익

비율

International Reconstructive

148.37M

26.55%

U.S. Reconstructive

137.88M

24.67%

U.S. Bracing & Support

115.09M

20.59%

International P&R

90.88M

16.26%

U.S. Other P&R

66.62M

11.92%

데이터 없음

사업별

지역별

사업별USD

이름

수익

비율

International Reconstructive

148.37M

26.55%

U.S. Reconstructive

137.88M

24.67%

U.S. Bracing & Support

115.09M

20.59%

International P&R

90.88M

16.26%

U.S. Other P&R

66.62M

11.92%

주식 보유 통계

마지막 업데이트: Thu, Jul 10

주주

주주 유형

주주

비율

BlackRock Institutional Trust Company, N.A.

11.41%

The Vanguard Group, Inc.

10.64%

American Century Investment Management, Inc.

6.17%

Davenport Asset Management

5.38%

Dimensional Fund Advisors, L.P.

5.12%

Other

61.27%

주주

비율

BlackRock Institutional Trust Company, N.A.

11.41%

The Vanguard Group, Inc.

10.64%

American Century Investment Management, Inc.

6.17%

Davenport Asset Management

5.38%

Dimensional Fund Advisors, L.P.

5.12%

Other

61.27%

주주 유형

주주

비율

Investment Advisor/Hedge Fund

46.99%

Investment Advisor

45.59%

Hedge Fund

7.67%

Research Firm

4.24%

Individual Investor

1.55%

Bank and Trust

1.35%

Pension Fund

1.15%

Family Office

0.05%

Sovereign Wealth Fund

0.05%

기관 주식 보유

마지막 업데이트: Tue, Jul 1

보고 기간

기관 수

보유 주식

비율

변동

2025Q2

630

68.25M

119.48%

-3.27M

2025Q1

646

68.39M

119.73%

-3.70M

2024Q4

637

64.20M

113.02%

-5.55M

2024Q3

613

62.53M

111.92%

-6.94M

2024Q2

617

64.91M

118.38%

-5.04M

2024Q1

651

62.70M

114.40%

-9.13M

2023Q4

661

61.64M

112.95%

-6.99M

2023Q3

653

60.52M

110.96%

-10.76M

2023Q2

641

59.95M

109.96%

-8.07M

2023Q1

643

57.38M

105.33%

-9.99M

주주 활동

이름

보유 주식

비율

변동

Chg %

날짜

BlackRock Institutional Trust Company, N.A.

6.52M

11.41%

+1.67M

+34.39%

Mar 31, 2025

The Vanguard Group, Inc.

6.08M

10.64%

-7.15K

-0.12%

Mar 31, 2025

American Century Investment Management, Inc.

3.52M

6.17%

+369.48K

+11.71%

Mar 31, 2025

Davenport Asset Management

3.07M

5.38%

-206.82K

-6.31%

Mar 31, 2025

Dimensional Fund Advisors, L.P.

2.93M

5.12%

+27.89K

+0.96%

Mar 31, 2025

Royce Investment Partners

2.49M

4.36%

+20.23K

+0.82%

Mar 31, 2025

State Street Global Advisors (US)

1.89M

3.32%

+162.41K

+9.37%

Mar 31, 2025

Diamond Hill Capital Management Inc.

1.87M

3.28%

-918.91K

-32.92%

Mar 31, 2025

Hood River Capital Management LLC

1.44M

2.53%

+781.15K

+118.10%

Mar 31, 2025

River Road Asset Management, LLC

1.39M

2.44%

+153.53K

+12.40%

Mar 31, 2025

26.290USD

Enovis Corp

26.290

개요

회사

금융